Diabetes Clinical Trials in San Francisco

Showing 41-60 of 405 trials

BETA - Pilot Study

NCT07192861

This study is testing the feasibility of using non-invasive, remote digital tools including continuous glucose monitors (CGMs) and Oura ring and the Empatica EmbracePlus smart wristband to predict the function of beta-cells, the cells in the pancreas that secrete insulin. This study is being initially done with individuals with Type 1 diabetes, so that in the future these methods can be tested in a larger study of individuals with Type 2 diabetes or prediabetics. The eventual aim of this work is to develop remote digital tools that can predict the health and functioning of the pancreas in people with prediabetes and Type 2 diabetes, allowing personalized treatment approaches to preserve insulin secretion.

Diabetes (DM)

4YouandMe28 participantsStarted Jul 2025

San Francisco, California, United States

RECRUITING< 1 mile

HLA Demographics Study in Adults With Type 1 Diabetes

NCT06860516

This is a study to evaluate the HLA-DRB1\*04:01 genotype in adults that have been diagnosed with type 1 diabetes

Diabetes Mellitus, Type I

GentiBio, Inc50 participantsStarted Jun 2025

San Francisco, California, United States • Gainesville, Florida, United States • Boston, Massachusetts, United States +2 more locations

RECRUITING< 1 mile

DFC 004 Biomarkers for Active Diabetic Foot Ulcers

NCT06104969

This study is a platform study designed to efficiently test multiple biomarkers to identify diabetic foot ulcers (DFUs) with a higher potential for healing versus not healing that ultimately could be applied at the point of care to drive personalized management decisions, and to better inform clinical trials of wound healing interventions

Diabetic Foot UlcerDiabetic FootDiabetes

University of Michigan5,000 participantsStarted Jun 2023

Tucson, Arizona, United States • Los Angeles, California, United States • San Francisco, California, United States +5 more locations

BETA - Pilot Study

HLA Demographics Study in Adults With Type 1 Diabetes

DFC 004 Biomarkers for Active Diabetic Foot Ulcers

Diabetes Trials in Other Cities

Continuous Glucose Monitoring System Feasibility in Youth With T2D

Assess the Efficacy and Safety of Repeat Intravitreal Injections of Foselutoclax (UBX1325) in Patients With DME (ASPIRE)

A Study of Orforglipron (LY3502970) Compared With Semaglutide in Participants With Type 2 Diabetes Inadequately Controlled With Metformin

A Study to Learn How Well the Study Treatment Finerenone Works and How Safe it is in People With Long-term Decrease in the Kidneys' Ability to Work Properly (Chronic Kidney Disease) Together With Type 1 Diabetes

A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Semaglutide (COMBINE 2)

A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 1 Diabetes Treated With Multiple Daily Injection Therapy

A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 2 Diabetes Currently Treated With Basal Insulin

Omnipod 5 System Compared to Pump Therapy

The Pediatric Artificial Pancreas Automated Initialization Trial

A Patient-Centered Strategy for Improving Diabetes Prevention in Urban American Indians

BEAD-T1D: Building the Evidence to Address Disengagement in Type 1 Diabetes

Evaluation of the MiniMed™ 780G System in Type 1 Adult and Pediatric Subjects Utilizing Insulin Fiasp®

A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes and Inadequate Glycemic Control With Insulin Glargine, With or Without Metformin and/or SGLT-2 Inhibitor

HbA1c Variation Study

Effect of Inhaled Technosphere Insulin vs RAA Insulin on Exercise-Induced Hypoglycemia in Adults With T1D Using Automated Insulin Delivery

An Efficacy, Safety, and Tolerability Study of VX-880 in Participants With Type 1 Diabetes With a Kidney Transplant

A Safety, Tolerability, and Efficacy Study of VX-264 in Participants With Type 1 Diabetes

Other Conditions in San Francisco